Mark R N Kotter
Overview
Explore the profile of Mark R N Kotter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1831
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davies B, Yang X, Khan D, Mowforth O, Touzet A, Nouri A, et al.
PLoS Med
. 2024 Aug;
21(8):e1004447.
PMID: 39173109
Background: Degenerative cervical myelopathy (DCM) is a progressive chronic spinal cord injury estimated to affect 1 in 50 adults. Without standardised guidance, clinical research studies have selected outcomes at their...
2.
Goacher E, Yardanov S, Phillips R, Budu A, Dyson E, Ivanov M, et al.
Br J Neurosurg
. 2024 May;
:1-5.
PMID: 38712620
Purpose: Degenerative cervical myelopathy (DCM) is the commonest cause of adult spinal cord dysfunction worldwide, for which surgery is the mainstay of treatment. At present, there is limited literature on...
3.
Yang X, Davies B, Coles J, Menon D, Stubbs D, Gharooni A, et al.
Brain Spine
. 2023 Nov;
3:102702.
PMID: 38021005
Introduction: The epidemiology and prognosis of the isolated traumatic brain injury (TBI) and spinal cord injury (SCI) are well studied. However, the knowledge of the impact of concurrent neurotrauma is...
4.
Sangeorzan I, Antonacci G, Martin A, Grodzinski B, Zipser C, Murphy R, et al.
JMIR Res Protoc
. 2023 Oct;
12:e46809.
PMID: 37812472
Background: Health care decisions are a critical determinant in the evolution of chronic illness. In shared decision-making (SDM), patients and clinicians work collaboratively to reach evidence-based health decisions that align...
5.
Davies B, Banerjee A, Mowforth O, Kotter M, Newcombe V
J Clin Neurosci
. 2023 Oct;
117:84-90.
PMID: 37783068
Background: Degenerative cervical myelopathy (DCM) arises from spinal degenerative changes injuring the cervical spinal cord. Most cord compression is incidental, referred to as asymptomatic spinal cord compression (ASCC). How and...
6.
Butler M, Vellaiyappan S, Bhatti F, Syed F, Rafati Fard A, Teh J, et al.
Front Med (Lausanne)
. 2023 Sep;
10:1237219.
PMID: 37675134
Study Design: Systematic review. Objective: The objective of this study was to evaluate the impact of phosphodiesterase (PDE) inhibitors on neurobehavioral outcomes in preclinical models of traumatic and non-traumatic spinal...
7.
Hastings N, Yu Y, Huang B, Middya S, Inaoka M, Erkamp N, et al.
Adv Sci (Weinh)
. 2023 Jul;
10(29):e2301756.
PMID: 37485646
Astrocytes are diverse brain cells that form large networks communicating via gap junctions and chemical transmitters. Despite recent advances, the functions of astrocytic networks in information processing in the brain...
8.
Davies B, Brannigan J, Mowforth O, Khan D, McNair A, Tetreault L, et al.
BMJ Open
. 2023 Jul;
13(7):e064296.
PMID: 37463815
Objectives: To explore whether a James Lind Alliance Priority Setting Partnership could provide insights on knowledge translation within the field of degenerative cervical myelopathy (DCM). Design: Secondary analysis of a...
9.
Patient, sufferer, victim, casualty or person with cervical myelopathy: let us decide our identifier
Boerger T, Davies B, Sadler I, Sarewitz E, Kotter M
Integr Healthc J
. 2023 Jul;
2(1):e000023.
PMID: 37441311
Among biomedical journals, person-first language is considered preferable to identity person-first language. However, not all populations of people with certain medical diagnoses, such as deafness, prefer person-first language. Moreover, adherence...
10.
Brannigan J, Mowforth O, Rogers M, Wood H, Karimi Z, Kotter M, et al.
JMIR Form Res
. 2023 May;
7:e45248.
PMID: 37159244
Background: Degenerative cervical myelopathy (DCM) is a common and disabling neurodegenerative condition. Surgical decompression is the only evidence-based treatment to halt disease progression; however, diagnosis and access to timely treatment...